Financial results for the period ended September 30, 2026
As filed · Gujarat Themis Biosyn Limited has submitted to the Exchange, the financial results for the period ended September 30, 2026.
EarningsMajormateriality 75 out of 100
What happened
FactFinancial results for the period ended September 30, 2026. Approved the unaudited standalone and consolodated financial results for the quarter & half year ended. The Financial Results alongwith Limited Review Report is attached herewith.
Why it matters
CapitSignal interpretationReported results are the point at which prior management commitments become checkable against audited or reviewed numbers.
Watch next
Fact- Margin trend against the prior period
- Cash from operations against reported profit
- Whether prior guidance is reaffirmed
- The transaction is expected to close by the end of Q3FY27 (Quarter Ending 31st December 2026), subject to cust (management committed by Q3 FY27)
Evidence
How CapitSignal classified this
- Reasoning:
- RESULTS base 68; +2 corroborating keywords; +5 quantified amount; matched on subject
- Matched on:
- the filing's own subject line
- Confidence in the event type:
- 90%